Annals of dermatology

Korean Dermatological Association (대한피부과학회)
권호 표지
DOI QR코드

DOI QR Code

Parry-Romberg Syndrome Augmented by Hyaluronic Acid Filler

  • Received : 2017.11.03
  • Accepted : 2017.12.11
  • Published : 2018.12.01
⟨ Previous Next ⟩

Abstract

Parry Romberg Syndrome (PRS), also known as idiopathic progressive hemifacial atrophy, is a rare neurocutaneous disorder characterized by loss of skin and subcutaneous fat of face, muscles, and bones causing unilateral atrophy. Most patients require only soft tissue augmentation although syndrome has varying grades of severity. In the majority of reported cases, it has been treated with surgical flap or autologous fat transplantation. However, these treatments need complicated surgical skills which take a lot of time and cost. Herein we report the first case of PRS augmented by hyaluronic acid (HA) filler in a 42-year-old female patient to suggest that HA filler could be a safe, simple, and even rational economic alternative to surgical treatment.

Keywords

References

  1. Hunstad JP, Shifrin DA, Kortesis BG. Successful treatment of Parry-Romberg syndrome with autologous fat grafting: 14-year follow-up and review. Ann Plast Surg 2011;67:423-425. https://doi.org/10.1097/SAP.0b013e31820b3aa8
  2. Balaji SM. Subdermal fat grafting for Parry-Romberg syndrome. Ann Maxillofac Surg 2014;4:55-59. https://doi.org/10.4103/2231-0746.133081
  3. Agostini T, Spinelli G, Marino G, Perello R. Esthetic restoration in progressive hemifacial atrophy (Romberg disease): structural fat grafting versus local/free flaps. J Craniofac Surg 2014;25:783-787. https://doi.org/10.1097/SCS.0000000000000831
  4. Alencar JC, Andrade SH, Pessoa SG, Dias IS. [Autologous fat transplantation for the treatment of progressive hemifacial atrophy (Parry-Romberg syndrome: case report and review of medical literatute)]. An Bras Dermatol 2011;86(4 Suppl 1):S85-88. Portuguese. https://doi.org/10.1590/S0365-05962011000700022
  5. Chang Q, Li J, Dong Z, Liu L, Lu F. Quantitative volumetric analysis of progressive hemifacial atrophy corrected using stromal vascular fraction-supplemented autologous fat grafts. Dermatol Surg 2013;39:1465-1473.
  6. Myung Y, Lee YH, Chang H. Surgical correction of progressive hemifacial atrophy with onlay bone graft combined with soft tissue augmentation. J Craniofac Surg 2012;23:1841-1844. https://doi.org/10.1097/SCS.0b013e318264b0ab
  7. Cox SE, Soderberg JM. Idiopathic hemifacial atrophy treated with serial injections of calcium hydroxylapatite. Dermatol Surg 2010;36:542-545. https://doi.org/10.1111/j.1524-4725.2010.01499.x
  8. Tollefson MM, Witman PM. En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients. J Am Acad Dermatol 2007;56:257-263. https://doi.org/10.1016/j.jaad.2006.10.959
  9. Chai G, Tan A, Yao CA, Magee WP 3rd, Junjun P, Zhu M, et al. Treating Parry-Romberg syndrome using three-dimensional scanning and printing and the anterolateral thigh dermal adipofascial flap. J Craniofac Surg 2015;26:1826-1829. https://doi.org/10.1097/SCS.0000000000001903
  10. Yu-Feng L, Lai G, Zhi-Yong Z. Combined treatments of facial contour deformities resulting from Parry-Romberg syndrome. J Reconstr Microsurg 2008;24:333-342. https://doi.org/10.1055/s-2008-1080536
  11. Al-Niaimi F, Taylor JA, Lyon CC. Idiopathic hemifacial atrophy treated with permanent polyacrylamide subdermal filler. Dermatol Surg 2012;38:143-145. https://doi.org/10.1111/j.1524-4725.2011.02241.x
  12. Park S, Park KY, Yeo IK, Cho SY, Ah YC, Koh HJ, et al. Investigation of the degradation-retarding effect caused by the low swelling capacity of a novel hyaluronic Acid filler developed by solid-phase crosslinking technology. Ann Dermatol 2014;26:357-362. https://doi.org/10.5021/ad.2014.26.3.357
  13. Bugge H, Negaard A, Skeie L, Bergersen B. Hyaluronic acid treatment of facial fat atrophy in HIV-positive patients. HIV Med 2007;8:475-482. https://doi.org/10.1111/j.1468-1293.2007.00494.x
  14. Becker M, Balague N, Montet X, Calmy A, Salomon D, Toutous-Trellu L. Hyaluronic Acid filler in HIV-associated facial lipoatrophy: evaluation of tissue distribution and morphology with MRI. Dermatology 2015;230:367-374. https://doi.org/10.1159/000379747
  15. Verpaele A, Strand A. Restylane SubQ, a non-animal stabilized hyaluronic acid gel for soft tissue augmentation of the mid- and lower face. Aesthet Surg J 2006;26(1s):S10-17. https://doi.org/10.1016/j.asj.2005.09.009
  16. Lee BM, Han DG, Choi WS. Rejuvenating effects of facial hydrofilling using restylane vital. Arch Plast Surg 2015;42:282-287. https://doi.org/10.5999/aps.2015.42.3.282